NEW YORK (GenomeWeb News) – Synthetic Genomics has sold one million shares to the Malaysian company Dragasic, a subsidiary of the Genting Group, for $8 million, Genting said today, according to the Malaysian news agency Bernama.
Genting said that the Class A common stock it purchased from Synthetic Genomics Founder, Chariman, and CEO Craig Venter represents a roughly two percent economic interest and three percent voting interest in the La Jolla, Calif.-based company.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

In Science this week: in vitro generation of human reproductive cells, and more.